CRSR vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CRSR

58.2
AI Score
VS
CRSR Wins

CLOV

48.9
AI Score

Investment Advisor Scores

CRSR

58score
Recommendation
HOLD

CLOV

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRSR CLOV Winner
Revenue 354.51M 749.19M CLOV
Net Income 12.78M 27.33M CLOV
Net Margin 3.6% 3.6% CLOV
Operating Income 13.80M 27.33M CLOV
ROE 2.0% 8.1% CLOV
ROA 1.1% 3.9% CLOV
Total Assets 1.18B 697.73M CRSR
Current Ratio 1.74 1.33 CRSR
Free Cash Flow 26.06M 107.04M CLOV

Relative Price Performance (Last 90 Days)

CRSR 1M: +12.2% · 3M: +56.3% CLOV 1M: -22.6% · 3M: +51.6%

Current Technical Phase

CRSR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.6% over 20 days), RSI 60

RSI (14): 59.8 · Price: $10.61

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.3 · Price: $4.17

Fundamentals Snapshot

Metric CRSR CLOV
Market Cap
Forward P/E 13.8 41.7
Trailing P/E 118.1
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.3% 0.2%
Operating Margin 0.0% 0.0%
EPS 0.09 -0.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRSR is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.